#nationwide vaccination drive
Text
The Weather
Similar to this time last year, COVID wastewater levels in many states have decreased and now remain at low levels except for the states of Tennessee and Missouri, which are at high levels. Arkansas, Alabama, Delaware, Minnesota, and Virginia have moderate viral levels detected by wastewater surveillance. This reminds us that it is important to continue the practice of precautions, especially among those most vulnerable to a COVID infection.
When considering trends in wastewater levels across all four regions, they have stopped decreasing as seen in the provisional data (gray shaded area). The national wastewater levels are indicated as “Low.” While lower wastewater levels indicate decreased spread, the risk for infection remains moderate especially as current wastewater levels remain slightly higher than previous low periods.
Wins
During the past few weeks, we have taken several actions against removing vital public health measures, especially the change in COVID isolation guidelines. This included the People’s CDC press conference from March 13, a recording and our press release are available. We also have a pre-proof of the People’s CDC External Review in the American Journal of Preventive Medicine Focus that additionally highlights the shortcomings of the CDC’s approach to public health and recommends a more equitable pandemic response. This week, we have assembled an expert letter asking the CDC to correct their COVID isolation guidelines.
Community groups continue to show us that it is possible to push back against corporate efforts to further privatize healthcare – and win. In Massachusetts, the Boston Center for Independent Living and SEIU 1199 led a successful drive to prevent cuts to publicly funded personal care attendants (PCAs) for disabled people. When we fight, we win.
Variants
Currently, JN.1 remains the dominant variant in the US, and is 83.7% of circulating variants as of 4/13/2024, down from 88.5% on 2/3/2024. JN.1.13 has increased to 9.1%, up from 0.7% on 2/3/2024. Other variants comprise 7.2% of the remaining total. A recent study, published in The Lancet Infectious Diseases, provided additional information on recent COVID variants that shed higher levels of wastewater; however, this cannot discount that COVID transmission remains at higher risk during rises in wastewater levels.
Hospitalizations
Total new hospital admissions caused by COVID have decreased to 7,318 during the week of April 6, 2024. Although the number of new hospital admissions are lower than the past, many counties in the US continue to experience increases in new hospital admissions. Over 25% of all counties are experiencing an increase in new COVID hospital admissions between the last week of March 2024 and the first week of April 2024. Most concerning, we still do not know the total number of hospital-acquired infections, since reporting over these numbers halted in May 2023. Despite this decrease in new hospital admissions and wastewater levels are currently at low levels nationwide, total hospitalizations do not completely reflect the current amount of circulating virus.
Prevention and Precautions
The CDC recently released guidelines to improve ventilation and implementation of air purification to prevent the spread of infectious diseases, specifically airborne pathogens. A group of scientists have also jointly published a policy statement in the academic journal Science supporting the establishment of higher standards for ventilation and the importance of air purification in indoor settings. Two studies published in the last month have validated the significance and value of both ventilation and air purification in schools and childcare centers to prevent the spread of COVID.
Vaccine uptake remains limited. Only 22.8% of adults and 14.1% of children have received the updated COVID vaccine as of 4/11/2024 - a slight increase from 21.1% of adults and 12.8% of children on 3/10/2024. The Bridge Program remains available for those underinsured or without insurance for no-cost access to these vaccines, but may end December 31, 2024.
Long COVID
Senator Bernie Sanders, as chair of the Senate Health, Education, Labor, and Pension Committee, proposed draft legislation to address Long COVID. This proposal aims to allocate $1 billion annually for a decade to the NIH for Long COVID research, establish a centralized research entity and advisory board, create a rapid grant process for clinical trials, develop a patient data database, and enhance public education on Long COVID. We ask that you share your thoughts to their official contact by email specifically on allocating funding for effective treatments and specific measures in the prevention of Long COVID by April 23, 2024. Currently, Long COVID Alliance has compiled a list of active opportunities in studies and clinical trials that people with Long COVID may participate in, which may help the clinical community contribute knowledge of Long COVID and potentially support the development of effective treatments.
Take Action
An invaluable home-based program that supports testing, evaluation, and treatment for COVID, Test to Treat program, is ending on April 16, 2024. Send a letter to your local representatives to ask them to help save the program that helps so many at-risk people!
It’s been over a month since the CDC released new, irresponsible guidelines on COVID isolation which are not substantiated by scientific evidence. Our fight to take public health out of the hands of corporate interests and protect our collective well-being continues. As part of our strategy to push back, we’ve put together an expert letter to CDC Director Mandy Cohen telling her to reinstate science-based COVID isolation guidelines. We urge the CDC to consider the highly variable length of infectiousness in their recommendations and to adopt a test-based approach for ending isolation. This letter is for public health professionals, scientists, healthcare workers, disability advocates, and others who consider themselves experts in public health. Sign this letter asking the CDC to correct their updated COVID isolation guidelines.
Avian Flu (Awareness Update)
The People’s CDC is monitoring Avian Influenza (AKA “Bird Flu”) as it has been spreading in many avian and mammalian species around the world at alarming rates. The current strain of concern is subtype H5N1 clade 2.3.4.4b and is highly pathogenic in poultry, causing systemic infections and rapid onset of illness and death among avian species (1). As such, this is called a highly pathogenic avian influenza (HPAI). This specific clade emerged in 2020 and has now been detected on every continent (2,3,4, 5). Over 500 species of birds and 360 species of other animals have been infected worldwide. Hundreds of thousands of wild animals have died from avian influenza since its emergence in 2020 (1, 6). Here in the U.S., at least 28 outbreaks have occurred in cattle farms (6, 7).
While human cases remain low, case fatality in humans has historically been around 50% (6). The outbreak among many non-bird animals is alarming and allows for opportunities for viral mutations that may lead to further infections among humans (1,6). The ecological consequences of such mass death around the world are currently unknown but guaranteed to be devastating as food webs are severely disrupted and conservation efforts suffer (1, 5). Humans are already feeling the direct impact of this as farmers are forced to cull entire flocks of poultry to control the spread, which may result in increased prices in the food supply (6). Humans will probably continue to feel the impacts of this historic spread, regardless of the number of human cases. We will continue to monitor the situation and share updates as the situation develops.
UC Davis
CDC
CDC
Viruses
Nature
Vox
BNO News
#op#covid19#covid-19#covid 19#pcdc#covid#people's cdc#cdc#coronavirus#pandemic#sars-cov-2#sars cov 2#covid news#long covid#covid pandemic#covid isn't over#covid conscious#covid is not over#avian flu#bird flu#h5n1#test to treat#uspol#covid prevention#covid levels#public health#coronavirus pandemic#links#img#described in alt text
12 notes
·
View notes
Text
India was able to save more than 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, according to a Stanford University report.
The campaign also yielded a positive economic impact by preventing a loss of $18.3 billion, the working paper by Stanford University and Institute for Competitiveness titled 'Healing the Economy: Estimating the Economic Impact on India's Vaccination and Related Issues' released by Union health minister Mansukh Mandaviya on Friday suggested.
According to the Stanford report, the direct and total impact of vaccination varied from about $ 1.03 billion to $ 2.58 billion if minimum wages are considered within the age distribution category.
“The same, however, varied from about $3.49 billion to $ 8.7 billion if GDP per person employed (constant) is considered. The cumulative lifetime earnings of the lives saved through vaccination (in the working age group) rolled up to $ 21.5 billion. Moreover, since vaccination also saved the lives of the elderly, this indirectly helped prevent the health infrastructure from getting overwhelmed and thereby allowing for a more judicious use of the existing health infrastructure,” the report suggested.
Mandaviya said much before Covid-19 was declared a public health emergency by the World Health Organisation (WHO) in January 2020, processes and structures to focus dedicatedly on various facets of the pandemic management were put in place...
The Stanford working paper refers to a Lancet modelling study which estimated that in India around 3.4 million deaths were prevented by vaccination in the year 2021, an estimate based on officially reported deaths in India.
The paper also highlighted the impact of the lockdown and referred to the health ministry’s statistical analysis that the Covid-19 tally could have reached about two lakh (0.2 million) without lockdown by April 11, 2020.
Due to lockdown measures, the actual cases only went up to about 7,500 by April 11, 2020, making a case for the lockdown stronger."
-via Times of India, 2/25/23
#india#covid#covid 19#vaccination#pandemic#covid relief#science and technology#public health#lockdown#good news#hope
42 notes
·
View notes
Text
ProTip: Get your free yearly COVID and flu vaccinations before heading to holiday gatherings where you may run into unvaccinated MAGA relatives.
Welcome to sick season. According to the CDC, New York City, along with New Jersey and at least 16 other states are now experiencing “high” to “very high” levels of respiratory illness activity, as measured by the number of weekly visits to healthcare providers and emergency rooms by people experiencing symptoms of fever, cough, and sore throat . The culprits are the usual suspects: this year’s strains of influenza, COVID, and RSV. And though flu-like illness levels have been above baseline nationally for several consecutive weeks, the CDC warns that we still haven’t hit the peak.
[ ... ]
The CDC also sent out an alert to healthcare providers this week highlighting low vaccination rates for the three viruses.
I never stopped wearing a mask on crowded public transit. An increasing number of commuters are resuming the practice.
Beyond vaccination, for everyone, the best way to prevent the spread of respiratory illnesses like the flu and RSV is regular handwashing; avoiding touching your eyes, nose, and mouth; and staying home if you get sick. High filtration face masks still work great, too, and not just for avoiding COVID.
Most of the time if a place offers COVID vaccines it also has flu vaccines. But just to be safe...
Vaccines.gov - Search for COVID‑19 vaccine locations
Vaccines.gov - Search for flu vaccine locations
At least at my CVS, they offer Novavax COVID vaccines free and without appointments. It might be necessary to schedule an appointment for flu and RSV vaccines.
10 notes
·
View notes
Text
If your government is paying lobbyists from your community maybe your not as oppressed as you say you are.
AU — . An Australian politician has revealed that “more than 30 federal departments and agencies” are paying a transgender and queer lobby group for “advice and staff training on so-called ‘inclusive’ language.”
Senator Claire Chandler, a Senator of Tasmania for the Liberal Party, said in an Op-Ed published on her website today that the federal Department of Health had last year replaced a pregnancy COVID-19 vaccination guide’s fifty references to ‘women’ with the phrase ‘pregnant person’.
Noting that “removal of specific sex-based language undermines the accuracy of health advice for pregnant women,” and the “overwhelming majority of Australians don’t find the re-labelling of mothers as ‘birthing parents’ or ‘pregnant people’ inclusive” but instead “unnecessary, sexist virtue-signalling,” Senator Chandler was motivated to contact the Department of Health to uncover what was driving its “ideological capture.”
In January, Senator Chandler queried the Department of Health about its “mind-boggling waste of resources during a pandemic.”
This month, she learned:
“The Department’s answer was that it receives ‘a benchmark and suggestions’ on ‘the use of inclusive language’ from the lobby group Pride in Diversity. Services Australia was presented with a “Gold Employer” award by the same lobby group this year, apparently around the same time it was starting to re-label mothers as ‘birthing parents’.”
Pride in Diversity is a program by the New South Wales-based ACON, which is described on its website as a “health promotion organisation” campaigning for “sexuality and gender diverse health.” The tax-exempt non-profit offers nationwide “services to assist employers, sporting organisations and service providers” with “inclusion” through its three programs, which aside from Pride in Diversity are Pride in Sport and Pride in Health + Wellbeing. ACON ranks employers by its “benchmarking instrument for LGBTQ workplace inclusion.” Employers who best conform to ACON’s standards are given incentives in the forms of high rankings on the Australian Workplace Equality Index (AWEI), which is published by ACON, as well as awards.
Senator Claire further revealed: “All up, more than thirty federal Departments and Agencies have been paying this lobby group for advice and staff training on so-called ‘inclusive’ language.”
This “influence of lobby groups over the public service” has been evident, as “the Office for Women declares that anyone who identifies as a woman is a woman, … Sport Australia encourages males who identify as women to play women’s sport,” and “Australian Bureau of Statistics claimed that humans can change sex over the course of their lifetime (a claim it was forced to amend after I asked them at Senate Estimates if they’d checked it with biologists).”
Further, the scheme has had “detrimental” effects on women’s human rights in Australia and internationally, with law and policy “increasingly allowing males to self-identify into women’s spaces and facilities, even housing male rapists in women’s prisons,” she said.
The Senator commended Sal Grover, founder and CEO of the app Giggle, for advocacy that resulted in the word ‘mother’ being restored on Medicare forms after it was temporarily replaced “with the de-sexed term ‘birthing parent’.” However, she stressed that fixing one form will not stop what is rapidly becoming systematic, with Australian taxpayer money intended for public services being used to fund an ideology that “drives … appalling disregard for women.”
3 notes
·
View notes
Text
US measles cases are up in 2024. What's driving the increase?
Measles outbreaks in the U.S. and abroad are raising health experts’ concern about the preventable, once-common childhood virus.
One of the world’s most contagious diseases, measles can lead to potentially serious complications. The best defense, according to experts? Get vaccinated.
Here’s what to know about the year — so far — in measles.
Nationwide, measles cases already are nearly double the…
View On WordPress
0 notes
Text
Soaring Heights: The Rise of Licensed Drone Companies in Nigeria
In recent years, Nigeria has witnessed a surge in the adoption of drone technology across various sectors, ranging from agriculture and infrastructure to security and healthcare. With this technological advancement comes the need for regulation and oversight, ensuring safety, security, and legality in drone operations. Licensed drone companies have emerged as key players in this burgeoning industry, navigating the regulatory landscape while providing innovative solutions to diverse challenges.
Licensed drone company in Nigeria undergoes rigorous processes to obtain legal authorization from regulatory bodies such as the Nigerian Civil Aviation Authority (NCAA). These companies comply with strict regulations regarding drone operation, pilot certification, and airspace management. By obtaining licenses, these companies demonstrate their commitment to operating within the legal framework, promoting safety, and upholding professional standards.
One of the primary sectors where licensed drone operators in Nigeria are making significant strides is agriculture. Nigeria's agriculture industry faces various challenges, including inefficient land management, crop monitoring, and pest control. Licensed drone companies leverage aerial imaging and data analytics to provide farmers with actionable insights, optimizing crop yields and resource utilization. From assessing soil health to monitoring crop growth, drones equipped with advanced sensors offer precise and timely information to farmers, empowering them to make informed decisions.
Infrastructure development is another area benefiting from the services of licensed drone companies. Nigeria's vast and diverse landscape presents unique challenges for infrastructure planning, construction, and maintenance. Drones equipped with high-resolution cameras and LiDAR technology enable efficient surveying and mapping of terrain, infrastructure assets, and construction sites. This data facilitates better planning, reduces project timelines, and enhances safety by identifying potential hazards and obstacles.
In the realm of security and surveillance, licensed drone companies play a pivotal role in augmenting traditional methods with cutting-edge technology. Drones equipped with thermal imaging cameras and AI-powered algorithms enhance surveillance capabilities, enabling law enforcement agencies to monitor large areas, detect suspicious activities, and respond swiftly to emergencies. Additionally, drones aid in search and rescue operations, providing aerial support in remote or inaccessible locations during disaster management scenarios.
Healthcare delivery in Nigeria is also being revolutionized by licensed drone companies, particularly in remote and underserved areas. Drones equipped with medical supplies, vaccines, and diagnostic equipment facilitates timely delivery of healthcare services, overcoming logistical challenges and improving accessibility. From transporting emergency medical supplies to conducting aerial surveys for disease surveillance, drones contribute to enhancing healthcare infrastructure and outcomes nationwide.
Despite the promising prospects, licensed drone companies in Nigeria face various challenges, including airspace restrictions, regulatory complexities, and public perception. Collaborative efforts between government agencies, industry stakeholders, and academia are essential to address these challenges and foster a conducive environment for the sustainable growth of the drone industry.
In conclusion, Drone Manufacturer in Nigeria is at the forefront of driving innovation and addressing societal challenges across diverse sectors. By adhering to regulatory requirements, harnessing advanced technology, and collaborating with stakeholders, these companies are shaping the future of aviation in Nigeria, unlocking new possibilities and opportunities for economic growth and development. As the industry continues to evolve, licensed drone companies will remain instrumental in harnessing the transformative power of drone technology for the benefit of society.
#Certified drone pilots in Nigeria#Drone Operations in Nigeria#Licensed drone company in Nigeria#Licensed drone operators in Nigeria#VTOL drone supplier in Nigeria#Hire drone pilot in Nigeria
0 notes
Text
RouteMedic Mobile Healthcare Units: Transforming Healthcare Accessibility in India
In a country as diverse and vast as India, ensuring access to quality healthcare can be a daunting challenge. However, RouteMedic Mobile Healthcare Units are paving the way for revolutionary change, particularly in regions like Mumbai and four key zones across the country. These units serve as dynamic conduits, bridging gaps in healthcare accessibility and saving lives in the process.
One of the primary functions of RouteMedic's mobile units is conducting health screenings directly on-site. This proactive approach enables early detection and intervention for common health issues such as hypertension, hypercholesterolemia, and diabetes. By bringing healthcare directly to communities and workplaces, these screenings play a crucial role in preventive healthcare, reducing the burden of disease and promoting overall well-being.
Moreover, RouteMedic's mobile units conduct vaccination drives, ensuring that communities have access to life-saving immunizations. From routine vaccinations like flu shots to targeted campaigns for diseases such as COVID-19, hepatitis, and tetanus, these initiatives bolster public health efforts and contribute to disease prevention on a large scale.
Corporate wellness programs are another integral aspect of RouteMedic's healthcare outreach. With offerings like stress management, smoking cessation, and nutrition counseling, these programs aim to promote holistic well-being among employees. By addressing both physical and mental health needs within the workplace, RouteMedic helps companies foster healthier, happier, and more productive work environments.
Emergency medical care is a critical service provided by RouteMedic's mobile units. Equipped with trained personnel and essential medical supplies, these units can respond swiftly to accidents, injuries, and sudden illnesses. Timely intervention can make a significant difference in patient outcomes, particularly in situations such as cardiac emergencies or severe injuries.
Occupational health services form another cornerstone of RouteMedic's healthcare portfolio. With over 30 Occupational Health Center (OHC) centers nationwide, RouteMedic caters to the health and safety needs of workers across various industries. Services such as hearing and vision tests, pulmonary function assessments, and medical examinations ensure that employees remain healthy and productive in their workplaces.
Telemedicine services provided by RouteMedic's mobile units bridge the gap between remote communities and healthcare providers. Through teleconsultations, patients can receive medical advice, diagnosis, and prescriptions without the need for physical travel. This innovative approach expands access to medical expertise and facilitates timely intervention, particularly in underserved areas.
Collaboration with certified partners such as Siddhant Marine enables RouteMedic to extend its services to maritime industries. By conducting medical examinations in compliance with shipping regulations, RouteMedic contributes to the health and safety of shipping crew members, ensuring they meet the required medical fitness standards for their roles.
Ambulance services offered by RouteMedic's mobile units provide vital transportation and medical care for patients requiring assistance during transit. Whether it's wheelchair transport or basic medical care en route to a healthcare facility, these services play a crucial role in ensuring timely access to medical attention.
On-site laboratory services facilitate prompt diagnosis and treatment, reducing the time to intervention for patients. With capabilities for blood tests, urine tests, and other diagnostic procedures, RouteMedic's mobile units empower healthcare providers to deliver timely care.
Health education and training initiatives conducted by RouteMedic's mobile units empower individuals and communities to take charge of their health. From CPR training to workplace safety workshops, these programs equip participants with essential skills and knowledge to respond effectively in emergencies.
In summary, RouteMedic's Mobile Healthcare Units are revolutionizing healthcare accessibility across India. From preventive screenings to emergency care and occupational health services, these units serve as pillars of healthcare outreach, ensuring that communities, businesses, and individuals have access to quality healthcare where and when they need it most.
Farhana Hayat's entrepreneurial spirit and passion for healthcare equity shine through in RouteMedic Mobile Healthcare Units' tireless efforts to serve communities in Mumbai and four key zones across India. As the driving force behind RouteMedic, Farhana has overseen the development of a comprehensive healthcare ecosystem that encompasses everything from preventive screenings to emergency medical care. Her forward-thinking approach has led to the implementation of corporate wellness programs, telemedicine services, collaboration with maritime industries, and more, all aimed at ensuring that healthcare remains accessible and inclusive for everyone. Farhana's leadership inspires innovation and compassion, driving RouteMedic's mission to save lives and improve health outcomes nationwide.
1 note
·
View note
Text
Steel Industry Contribution to Pakistan’s GDP
Steel stands out as one of the most essential materials across various sectors of the economy, including construction, transportation, manufacturing, and energy. Its pivotal role in the economic development of Pakistan cannot be overstated. The steel industry significantly contributes to the country's GDP and exerts a profound impact on diverse sectors. Over the past five years, this sector has demonstrated remarkable growth, with statistics underscoring its positive influence on the national exchequer. It also serves as a significant source of employment, income, and tax revenues. In this blog post, we will delve into how the steel industry in Pakistan is bolstering the nation's GDP and enriching the national exchequer.
According to the Pakistan Credit Rating Agency (PACRA), the steel industry holds a share of approximately 5.4% in the large-scale manufacturing (LSM) sector, which itself contributes around 9.5% to the GDP. With more than 100,000 workers employed across over 400 industrial units nationwide, the steel industry plays a crucial role in job creation. In 2019, the industry boasted a production capacity of 3.3 million tons, representing 0.18 percent of global production. Key players in the organized sector include FF Steel, Amreli, Agha, Mughal, Naveena, and Ittefaq Steels.
Moreover, the steel industry serves as a significant revenue source for the national exchequer through various taxes, royalties, and duties. PACRA reports that the steel sector contributes approximately 9.1% to the GDP, with an estimated year-on-year growth of 10.5% in FY22. Around 30% of the corporate tax is paid by the steel sector, collected from 30 public listed companies directly or indirectly associated with the industry. Additionally, the sector actively supported COVID-19 relief efforts, awareness campaigns, and vaccination drives in Pakistan, allocating roughly Rs 22,000 crore to corporate social responsibility (CSR) projects in FY 2021.
Expectations for the steel industry's continued growth remain high, driven by increasing demand for steel products both domestically and internationally. The government has also implemented several initiatives to bolster the sector, including corporate tax rate reductions, incentives for domestic production, and the introduction of the Development of Enterprise and Service Hubs (DESH) Bill aimed at revamping existing Special Economic Zones.
In conclusion, as sturdy as the steel it produces, Pakistan's steel industry stands tall as a cornerstone of economic prosperity. With its foundations deeply rooted in construction, transportation, manufacturing, and energy, this industry forges a path of growth, bolstering the nation's GDP and enriching the national exchequer. From towering skyscrapers to robust infrastructure, steel shapes the landscape of progress. As we look ahead, the future gleams bright with promise, as the steel industry continues to forge ahead, driving innovation, prosperity, and a stronger, more resilient Pakistan.
(1) STEEL SECTOR - PACRA. https://www.pacra.com/sector_research/Steel%20Sector%20Post%20Review%20Update_1601130113.pdf.
(2) LSM - Pakistan Steel Industry Outlook - PIDE - Pakistan's premier .... https://pide.org.pk/research/lsm-pakistan-steel-industry-outlook/.
(3) undefined. https://www.pacra.com/sector_research/PACRA%20Research%20-%20Steel%20-%20Sep.
(4) Pakistan - GDP distribution across economic sectors 2022 - Statista. https://www.statista.com/statistics/383256/pakistan-gdp-distribution-across-economic-sectors/.
(5) mwpbnp.pk. https://bing.com/search?q=Pakistan+steel+industry+GDP+contribution.
(6) mwpbnp.pk. https://mwpbnp.pk/blog6.html.
(7) Sector Study - PACRA. https://www.pacra.com/sector_research/PACRA%20Research%20-%20Steel%20-%20Sep'21_1630576235.pdf.
(8) Sector Study - PACRA. https://www.pacra.com/sector_research/PACRA%20Research%20-%20Steel%20-%20Sep'22_1662124643.pdf.
0 notes
Text
Pediatric Vaccines is Estimated to Witness High Growth Owing to Increased Government
Pediatric vaccines are vaccines administered to children during early life. Some of the key pediatric vaccines available in the market include pneumococcal vaccines, polio vaccines, MMR (measles, mumps, and rubella) vaccines, hepatitis vaccines, rotavirus vaccines, meningococcal vaccines, influenza vaccines, among others. These vaccines help prevent various life-threatening diseases and infections in children. Increased government initiatives to promote immunization programs globally have played a key role in improving children’s immunization rates. The global Pediatric Vaccines Market is estimated to be valued at US$ 46,424.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Increased government immunization programs present a key growth opportunity for the pediatric vaccines market. Various governments across the world are investing heavily in mass immunization programs to ensure high immunization rates among children. For instance, the Indian government’s Universal Immunization Program (UIP) aims to immunize all children up to 2 years of age against twelve vaccine-preventable diseases. Similarly, governments in the U.S., UK, China, Brazil and others are implementing effective nationwide immunization programs. The strong impetus by governments to promote immunization is expected to drive the demand for pediatric vaccines, especially in developing regions. This will encourage vaccine manufacturing companies to develop new and improved pediatric vaccines to capitalize on this opportunity.
Porter’s Analysis
Threat of new entrants: New entrants face high costs associated with R&D, clinical trials, and licensing requirements. Stringent regulations imposed by regulatory bodies further increase barriers.
Bargaining power of buyers: Buyers have low bargaining power as vaccines market is highly consolidated and R&D for new vaccines requires huge investments. Switching costs for buyers are also high.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to specialized expertise and long term contracts with manufacturers. However, presence of alternatives balances it.
Threat of new substitutes: Threat of substitutes is low as vaccines have few alternatives for preventing infectious diseases.
Competitive rivalry: Market is dominated by few global players. Intense competition exists on the basis of portfolio expansion and vaccines pricing.
SWOT Analysis
Strength: High unmet needs for new vaccines and immunization programs. Increasing government support and initiatives to promote immunization.
Weakness: High R&D costs and stringent regulations increase entry barriers. Pipeline depends on success rate of clinical trials.
Opportunity: Emerging economies provide high growth potential. Collaborations aid expansion into new geographies and product lines.
Threats: Pricing pressures to make vaccines affordable. Outbreaks of contagious diseases challenge current immunization.
Key Takeaways
The global pediatric vaccines market is expected to witness high growth over the forecast period. Vaccines are the most effective way to prevent infectious diseases in children. However, limited availability and affordability in developing nations persists. The global Pediatric Vaccines Market is estimated to be valued at US$ 46,424.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023-2030.
Key players operating in the pediatric vaccines market are GlaxoSmithKline, Merck, Sanofi, Pfizer, and Mylan. GlaxoSmithKline leads the market with its wide portfolio of pediatric vaccine brands like Infanrix and Pediarix. New vaccines in pipeline focusing on respiratory infections, meningococcal disease, and Ebola can further aid market expansion.
0 notes
Text
Pakistan Launches Anti Polio Drive
Pakistan launched its second nationwide anti-polio campaign of the year Monday in an effort to inoculate 44 million children under the age of 5 amid signs the country was close to eradicating the disease.
Caretaker Prime Minister Anwaarul-Haq-Kakar launched the five-day vaccination campaign in the capital, Islamabad, and urged parents in a televised address to cooperate with the 350,000 health workers who are going door-to-door to administer vaccine drops to children.
https://abcnews.go.com/amp/Health/wireStory/pakistan-launches-anti-polio-vaccine-drive-targeting-44m-103651651
0 notes
Text
📆 18 Sep 2023 📰 New COVID variant BA.2.86 spotted in 10 states, though highly mutated strain remains rare 🗞 CBS News
People across at least 10 states have now been infected by BA.2.86, a highly mutated variant of the virus that causes COVID-19 that authorities have been closely tracking.
According to data tallied from the global virus database GISAID, labs have reported finding BA.2.86 in samples from Colorado, Maryland, Michigan, New York, Ohio, Oregon, Pennsylvania, Texas, Virginia and Washington.
Estimates suggest BA.2.86 still remains a small fraction of new COVID-19 cases nationwide.
"The diversity is less than what appears. Many of these lineages actually have identical spike sequences. We've observed this before, where we see convergent evolution and viruses evolving to have the same substitutions," said Natalie Thornburg, a laboratory branch chief in the CDC's Coronaviruses and Other Respiratory Viruses Division.
Thornburg, who was speaking at a meeting of the agency's vaccine advisers last week, said it was still too early to know "if BA.2.86 will be of any significant circulation."
Health authorities do believe BA.2.86 is continuing to spread widely around the world, after scientists first voiced concern in August over the strain's large number of mutations.
"We are concluding this because some of the people infected with BA.2.86 do not have known links to other infected individuals and did not recently travel to an area with known cases of illness from BA.2.86," the CDC said Friday in a risk assessment.
Too few sequences of the virus have been reported to show up on the Centers for Disease Control and Prevention's biweekly variant estimates, which still show that a long list of closely related XBB variant descendants are driving virtually all infections around the country.
Research on BA.2.86 so far has so far largely relied on pseudoviruses, which are other viruses mocked up in a lab to mimic BA.2.86's distinctive mutations. Better findings will need to use viruses grown from actual samples of infected patients, a process which is now underway.
"CDC has generated two authentic isolates of BA.2.86. One confirmed and one putative. We are in the process of distributing BA.2.86 viruses to multiple labs to do transmission studies, more neutralization studies, against lots of different kinds of sera," said Thornburg.
For now, officials have expressed "guarded hope" about signs the current late summer wave of COVID-19 driven by other variants has passed its peak.
Meanwhile, scientists have already tracked BA.2.86 beginning to evolve into at least two different branches. Cases from both sublineages have been spotted in the U.S. so far, among the handful of cases reported globally so far.
"That's likely the tip of the iceberg, given that we know we don't have complete sequencing coverage," Kirking said.
0 notes
Text
Liquid Handling Systems Market Worth $6.99 Billion by 2029 – Exclusive Report by Meticulous Research®
According to a new market research report, ‘Liquid Handling Systems Market By Type (Automated, Electronic, Manual), Product (Pipette, Consumables, Burette, Software, Microplate), Application (Drug Discovery, Cancer & Genomics, Clinical), End User (Hospital, Diagnostic Lab) – Global Forecast to 2029,’ published by Meticulous Research®, the liquid handling systems market is projected to reach $6.99 billion by 2029, at a CAGR of 6.4% from 2022 to 2029.
Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5397
A liquid handling system involves any equipment used for transferring liquids in a laboratory from a pipette to the multifunction workstation. Liquid handling is usually required in the laboratory for various applications such as ELISA, nucleic acid preparation, PCR reaction, next-generation sequencing for genomic research, and liquid-liquid extraction. Liquid handling systems are crucial in increasing laboratory procedures requiring high-throughput screening.
Major factors driving the liquid handling systems market are the rapid growth and expansion of the pharmaceutical & biotechnology industry, increasing R&D expenditure of biopharmaceutical companies, rapid adoption of automation in laboratories, and growing demand for high-throughput screening. Furthermore, emerging economies and growing genomics and proteomics research are expected to provide significant growth opportunities for this market.
However, the high costs of automated liquid handling systems are expected to restrain the growth of this market to a notable extent. In addition, factors such as the slow adoption of automation among small & medium-sized laboratories and additional training required by the laboratory personnel for operating automated robotic liquid handling workstations are the major challenges to the growth of this market.
The Impact of COVID-19 on the Liquid Handling Systems Market
The coronavirus disease (COVID-19) outbreak in March 2020 impacted nearly every country around the globe. According to the WHO, as of 17th November 2022, there were 633.2 million confirmed cases and 6.6 million confirmed deaths. During the initial months of the pandemic, there were nationwide lockdowns and restrictions in several countries. This led to a global supply chain disruption and shortages of equipment & consumables. Further, according to the International Monetary Fund, the pandemic shrunk the global economy by about 3.5% in 2020. These factors had a short-term negative impact on the global liquid handling systems market.
However, due to the pandemic, there was an increased demand for COVID-19 testing in laboratories. Large volumes of samples were to be tested, and liquid handling systems were a crucial part of performing these tests. This led to an increased demand for liquid handling systems in clinical diagnostics laboratories. In addition, there was an increased demand for drug discovery and vaccine development. The demand for various types of liquid handling systems in pharmaceutical and biotechnology companies also increased. Thus, the COVID-19 pandemic ultimately had a positive impact on the liquid handling systems market.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5397
The liquid handling systems market is segmented by Type (Automated Liquid Handling Systems, Electronic Liquid Handling Systems, and Manual Liquid Handling Systems), Product (Pipettes [Semi-Automated Pipettes, Manual Pipettes, and Electronic Pipettes], Consumables, Liquid Handling Workstations, Burettes, Software, Microplate Reagents Dispensers, Microplate Washers, and Other Products), Application (Drug Discovery, Cancer & Genomics Research, Clinical Diagnostics, and Other Applications), End User (Hospitals & Diagnostic Laboratories, Biotechnology & Pharmaceutical Industries, Research & Academic Institutes, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.
Based on type, in 2022, the automated liquid handling systems segment is expected to account for the largest share of the liquid handling systems market. The large market share of this segment is attributed to factors such as the increased demand for high-throughput screening, the advantages of automated liquid handling systems, and the increased capabilities of end users to acquire advanced automated liquid handling systems.
Based on product, in 2022, the pipette segment is expected to account for the largest share of the liquid handling systems market. The large market share of this segment is attributed to the basic utility of pipettes in the liquid handling process and its applicability in a wide range of applications such as in sample preparation, serial dilution, and various types of assays.
Based on application, in 2022, the drug discovery segment is expected to account for the largest share of the liquid handling systems market. This segment’s large market share is attributed to the high demand for newer personalized drugs for treating a wide range of diseases, increased R&D expenditure, and increased focus on the efficient development of new drugs through molecular screening.
Based on end user, in 2022, the biotechnology & pharmaceutical industries segment is expected to account for the largest share of the liquid handling systems market. The large market share of this segment is attributed to the higher demand for liquid handling systems in the biotechnology & pharmaceutical industry, especially for drug discovery and manufacturing applications, and increased R&D expenditure in biopharma companies.
Quick Buy – Liquid Handling Systems Market- Global Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/54879600
Based on geography, in 2022, North America is expected to account for the largest share of the liquid handling systems market, followed by Europe and Asia-Pacific. North America’s large market share is attributed to its robust healthcare and R&D infrastructure, high R&D spending and investments, collaborations with large academic universities and the presence of key players in the region.
The report also includes an extensive assessment of the type, product portfolio, application, end user, and geography, and key strategic developments adopted by leading market participants in the industry over the past years (2020–2022). In recent years, the liquid handling systems market has witnessed numerous product launches & approvals, agreements, collaborations, partnerships, and mergers & acquisitions.
Some of the key players operating in this market study are Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), PRIMADAG SAS (France), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Mettler-Toledo International, Inc (U.S.).
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/liquid-handling-systems-market-5397
Scope of the Report:
Liquid Handling Systems Market, by Type
Automated Liquid Handling Systems
Electronic Liquid Handling Systems
Manual Liquid Handling Systems
Liquid Handling Systems Market, by Product
Pipettes
Semi-automated pipettes
Manual Pipettes
Electronic Pipettes
Consumables
Liquid Handling Workstations
Burettes
Software
Microplate Reagents Dispensers
Microplate Washers
Other Products
(Other Products include stackers, flocculation tester, pipetting aid, and laboratory glassware)
Liquid Handling Systems Market, by Application
Drug Discovery
Cancer & Genomics Research
Clinical Diagnostics
Other Applications
(Other applications include proteomics, bioprocessing in biotechnology, basic research, and microbiology)
Liquid Handling Systems Market, by End User
Hospitals & Diagnostic Laboratories
Biotechnology & Pharmaceutical Industries
Research & Academic Institutes
Other End users
(Other end users include contract research organizations, forensic laboratories, and government laboratories)
Liquid Handling Systems Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5397
0 notes
Text
Business News Trends in India.
The business environment in India is constantly changing, with innovations and trends emerging every day. In this article, we examine today's business news in India and how the country's business landscape is changing.
One of the hottest business news in India today is the rise of e-commerce. Online shopping has become popular in India over the past few years, with millions of people using platforms like Amazon and Flipkart to buy everything from electronics to clothing. According to a report by RedSeer Consulting, this trend will continue, and e-commerce is expected to grow by 30% by 2023.
Another critical factor in the Indian market is the rise of renewable energy. Companies in India are investing more in wind, solar, and other renewable energy sources as the government pushes for a clean energy transition. According to the top business news websites, India has set a target of installing 450 GW of renewable energy by 2030, which is expected to create significant opportunities for companies operating in these sectors.
At the same time, as the business grew, the geographical perspective in India became clear. With the COVID-19 pandemic underscoring global supply shortages, many companies seek local raw materials and products.
This should drive growth in activities such as manufacturing and distribution as companies strive to create better products.
RBI maintains the status quo in interest rates: In its April Monetary Policy Statement, the Reserve Bank of India (RBI) decided to maintain the status quo. The repo rate (the rate at which the central bank lends to banks) is 4%, while the repo rate (the rate at which banks deposit excess funds into the RBI) is 3.35%, according to some top news business websites. The RBI also announced measures to facilitate small businesses and MSMEs.
In today's business news, the Indian economy to grow by 10.1% in FY22: The International Monetary Fund (IMF) expects the Indian economy to grow by 10.1% in 2021-22, driven by the recovery in production and services, according to its latest forecast. The country's future development has been marred by the rise in COVID-19 cases and the slow vaccination rate.
India's exports in March increased by 60.29%: India's exports grew by 60.29% year-on-year in March 2021, according to the Ministry of Trade and Industry data. Growth is driven by solid demand for engineered products, pharmaceuticals, gemstones, and jewelry. However, as the business grows, the agency warned that the rise in COVID-19 cases and the shortage of containers and ships could worsen exports in the coming months.
The inflation rate increased to 5.52% in March: Retail price inflation, as measured by India's Consumer Price Index (CPI), rose to 5.52% in March 2021, mainly due to higher food prices. RBI said inflation is expected to rise amid higher oil prices and supply cuts in the coming months.
HDFC Bank Q4 revenue up 18%: HDFC Bank, India's largest lender, reported revenue of Rs 8,886 ($1.1 billion) for the fourth quarter ended March 2021, up 18% from a year ago.
Bank's assets increased, and total non-performing assets decreased to 1.32% from 1.38% in the previous quarter.
India's economic outlook rapidly evolves with products such as e-commerce, renewable energy, real estate, and construction.
As the industry continues to adapt to these trends, there are many opportunities for growth and success in the years ahead.
In addition, the Indian business environment has increased the cost of innovation. With many skilled workers and a thriving business ecosystem, India has emerged as an innovation hub in recent years. From Fintech to Edtech to Medtech, Indian startups are disrupting traditional industries and creating new business opportunities nationwide.
0 notes
Text
Covid: India reports 7,178 new Covid cases in last 24 hours | India Newsindia
NEW DELHI: India reported 7,178 new coronavirus infections, according to the Union health ministry data updated on Monday.
The active cases have dipped after 69 days and now stand at 65,683.
The death toll has increased to 5,31,345 with 16 deaths, which includes eight reconciled by Kerala, the data updated at 8 am stated.
The daily positivity rate has been recorded at 9.16 per cent and the weekly positivity rate was pegged at 5.41 per cent.
The Covid case tally was recorded at 4.48 crore.
The active cases now comprise 0.15 per cent of the total infections and the national Covid-19 recovery rate has been recorded at 98.67 per cent, the ministry said.
The number of people who have recuperated from the disease surged to 4,43, 01,865 while the case fatality rate was recorded at 1.18 per cent.
According to the ministry's website, 220.66 crore doses of Covid vaccine have been administered in the country so far under the nationwide vaccination drive.
0 notes
Text
Covid-19 instances in India: India's total Covid-19 tally climbed to 35,199. 5,880 new instances recorded within the final 24 hours. The demise toll elevated to five,30,916 with 12 demise, the info up to date at 8 am said. The every day positivity fee has been recorded at 6.91 per cent and the weekly positivity fee at 2.03 per cent. In line with the ministry's web site, 220.66 crore doses of Covid vaccine have been administered thus far beneath the nationwide inoculation drive. A nationwide mock drill to take inventory of hospital preparedness shall be held for 2 days by which each private and non-private services are anticipated to take part. Union Well being Minister Mansukh Mandaviya will go to AIIMS, Jhajjar on April 10 to supervise the mock drill, officers stated on Sunday.
COMMERCIAL BREAKSCROLL TO CONTINUE READINGWithin the assembly with state health ministers, and principal and extra chief secretaries held just about, Mandaviya had pressured the necessity to determine emergency hotspots by monitoring developments of influenza-like sickness (ILI) and extreme acute respiratory an infection (SARI) instances, ramping up testing and vaccination, and making certain readiness of hospital infrastructure.
Mandaviya had stated that regardless of the brand new variants, the five-fold technique of 'Check-Observe-Deal with-Vaccinate and adherence to Covid-Acceptable Behaviour' continues to stay the examined technique for Covid administration.
States and union territories have been additionally requested to expeditiously enhance the speed of testing from 100 assessments per million as on the week ending April 7. They have been additional suggested to extend the share of RT-PCR in assessments.
The most typical signs of COVID-19 are
Fever
Dry cough
Fatigue
Lack of style or scent,
Nasal congestion,
Conjunctivitis (also called purple eyes)
Sore throat,
Headache,
Muscle or joint ache,
0 notes
Last Seen Blogs
